PROBLEM TO BE SOLVED: To provide a medicine for prevention of and/or treatment for arteriosclerosis hypertension cardiac diseases kidney diseases or cerebrovascular diseases. SOLUTION: The medicine comprises following ingredients as active ingredients: (A) an angiotensin II receptor antagonist selected from a group consisting of olmesartan medoxomil etc. and its pharmacologically acceptable salts; and (B) a calcium antagonist selected from a group consisting of 14-dihydropyridine compounds and ...

Disclosed is a pharmaceutical composition containing olmesartan medoxomil and amlodipine, which has improved dissolvability. The pharmaceutical composition contains (A) olmesartan medoxomil, (B) amlodipine and (C) a calcium-containing additive.

The invention relates to a stable solid dosage form comprising olmesartan medoxomil and amlodipine or a pharmacologically acceptable salt thereof. In particular, it relates to solid dosage forms free from reducing sugars. The stable solid dosage form may optionally further comprise hydrochlorothiazide or a pharmacologically acceptable salt thereof.

The invention relates to a stable solid dosage form comprising olmesartan medoxomil and amlodipine or a pharmacologically acceptable salt thereof. In particular, it relates to solid dosage forms free from reducing sugars. The stable solid dosage form may optionally further comprise hydrochlorothiazide or a pharmacologically acceptable salt thereof.